We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+15.73%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$11.4B
AUM Growth
+$1.02B
Cap. Flow
-$761M
Cap. Flow %
-6.65%
Top 10 Hldgs %
38.51%
Holding
1,217
New
80
Increased
450
Reduced
355
Closed
36

Top Buys

Rank Stock Value
1
PSA icon
Public Storage
PSA
+$250M
2
EQIX icon
Equinix
EQIX
+$102M
3
EXR icon
Extra Space Storage
EXR
+$63.2M
4
INVH icon
Invitation Homes
INVH
+$48.9M
5
PEB icon
Pebblebrook Hotel Trust
PEB
+$41.9M

Top Sells

Rank Stock Value
1
VNO icon
Vornado Realty Trust
VNO
+$172M
2
CCI icon
Crown Castle
CCI
+$121M
3
DOC icon
Healthpeak Properties
DOC
+$101M
4
VTR icon
Ventas
VTR
+$100M
5
SBAC icon
SBA Communications
SBAC
+$96.7M

Sector Composition

Rank Sector Weight
1 Real Estate 74.34%
2 Technology 3.93%
3 Industrials 3.02%
4 Financials 2.65%
5 Healthcare 2.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SYRS
1126
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$2K ﹤0.01%
+22
New +$1.53K
EIGR
1127
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$2K ﹤0.01%
+4
New +$1.6K
IMGN
1128
DELISTED
Immunogen Inc
IMGN
$2K ﹤0.01%
731
– –
KDNY
1129
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$2K ﹤0.01%
85
– –
CNCE
1130
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$2K ﹤0.01%
126
– –
TWTR
1131
PUT
DELISTED
Twitter, Inc.
TWTR
$2K ﹤0.01%
+2,751
New +$87.2K
FPRX
1132
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$2K ﹤0.01%
160
– –
PGNX
1133
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$2K ﹤0.01%
388
– –
ACHN
1134
DELISTED
Achillion Pharmaceuticals
ACHN
$2K ﹤0.01%
762
– –
INSY
1135
DELISTED
Insys Therapeutics, Inc.
INSY
$2K ﹤0.01%
405
– –
ABUS icon
1136
Arbutus Biopharma
ABUS
$885M
$1K ﹤0.01%
304
– –
ACET icon
1137
Adicet Bio
ACET
$76.9M
$1K ﹤0.01%
+2
New +$1.82K
ACRS icon
1138
Aclaris Therapeutics
ACRS
$744M
$1K ﹤0.01%
170
– –
ADAP
1139
DELISTED
Adaptimmune Therapeutics
ADAP
$1K ﹤0.01%
323
– –
AQST icon
1140
Aquestive Therapeutics
AQST
$471M
$1K ﹤0.01%
+163
New +$1.14K
COGT icon
1141
Cogent Biosciences
COGT
$6.95B
$1K ﹤0.01%
+49
New +$838
DBVT
1142
DBV Technologies
DBVT
$815M
$1K ﹤0.01%
13
– –
EYPT icon
1143
EyePoint Inc
EYPT
$1.05B
$1K ﹤0.01%
+62
New +$1.47K
FBRX icon
1144
Forte Biosciences
FBRX
$1.57B
– –
0
– –
GERN icon
1145
Geron
GERN
$949M
$1K ﹤0.01%
880
– –
KALA icon
1146
KALA BIO
KALA
$12.2M
– –
0
– –
LRMR icon
1147
Larimar Therapeutics
LRMR
$403M
$1K ﹤0.01%
+20
New +$1.02K
OCUL icon
1148
Ocular Therapeutix
OCUL
$1.91B
$1K ﹤0.01%
+268
New +$1.08K
SVRA icon
1149
Savara
SVRA
$1.13B
$1K ﹤0.01%
169
– –
SYBX
1150
DELISTED
Synlogic
SYBX
$1K ﹤0.01%
+11
New +$1.35K
44 45
46
47 48

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q1 2019 Portfolio in Review

As of Q1 2019, Daiwa Securities Group held 1,217 positions worth $11.4B, up 9.8% from $10.4B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Daiwa Securities Group withdrew a net $761M in Q1 2019, closing 36 positions and reducing 355 holdings. Its most notable exit was CenterPoint Energy, Inc. Depositary Shares Each Representing a 1/20th Interest in a Share of 7.00% S, an estimated $15.1M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 74% of assets, down from 75% a quarter earlier, followed by Technology and Industrials.

Against the trend, Daiwa Securities Group opened a new position in Steris worth $13.7M.

  • Daiwa Securities Group's largest Q1 2019 buy was Steris: 106,969 shares worth $13.7M.
  • Daiwa Securities Group added most to Public Storage in Q1 2019, an estimated $250M increase.
  • Daiwa Securities Group's biggest Q1 2019 reduction was Vornado Realty Trust, cutting an estimated $172M.
  • Daiwa Securities Group fully exited CenterPoint Energy, Inc. Depositary Shares Each Representing a 1/20th Interest in a Share of 7.00% S in Q1 2019, selling an estimated $15.1M.
  • Daiwa Securities Group's ten largest holdings make up 39% of its $11.4B portfolio in Q1 2019.
  • Daiwa Securities Group opened 80 new positions and closed 36 in Q1 2019.
  • Daiwa Securities Group's portfolio value rose 9.8% quarter-over-quarter to $11.4B.

Based on Daiwa Securities Group's 13F filing for Q1 2019, filed 26 Apr 2019.